POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (6.15.2021, 11:19am CEST, WHO):   U.S. 8,197    India 70,421    Brazil 37,948    France 2,850    Turkey 5,012    Russia 13,721    The United Kingdom 7,319    Italy 1,390    Argentina 13,043    Columbia 28,519    Iran 10,715    Mexico 1,707    Peru 2,566    Indonesia 8,189    South Africa 7,657    The Netherlands 1,066    Chile 6,190    Canada 1,120    Philippines 6,426    Iraq 5,040    Pakistan 1,019    Bangladesh 3,050    Japan 1,076    Malaysia 4,949    Nepal 2,049    United Arab Emirates 1,837    Saudi Arabia 1,109    Bolivia 1,607    Paraguay 1,786    Panama 1,573    Tunisia 1,316    Uruguay 2,043    Kuwait 1,563    Venezuela 1,377    Oman 1,806    Sri Lanka 2,284    Thailand 3,355    Cuba 1,349    Zambia 1,414    Afghanistan 1,814    Mongolia 2,263    Uganda 1,727    China 206    Singapore 25    New Zealand 1    Australia 14    South Korea 374   

UK: 57% of all adults received first dose of COVID-19 vaccine

Christian Fernsby |
More than 30 million people in the UK have received a first dose of the COVID-19 vaccine as the NHS prepares to administer millions of second doses in the coming weeks.

Article continues below

The UK health services vaccinated a total of 30,151,287 people between 8 December and 27 March with first doses - around 57% of all UK adults. In addition, 3,527,481 people have had their second doses, totalling 33,678,768 jabs administered overall.

Around 6% of the adult population have had their second doses so far and there will be a strong push over the coming weeks to give people their second jabs in line with the 12 week dose interval.

The rollout is continuing at pace and the UK is on track to achieve the Prime Minister’s target of offering all over-50s and the clinically vulnerable their first vaccine by 15 April, as well as all adults by the end of July.

The speed of the vaccination programmes means even more people will soon develop strong protection from serious illness from coronavirus (COVID-19) infection, saving countless lives and significantly reducing pressure on the NHS.

All vaccines being used in the UK have undergone robust clinical trials and have met the Medicines and Healthcare products Regulatory Agency (MHRA) strict standards of safety, effectiveness and quality.

The Moderna vaccine has also been approved by the MHRA and will be deployed from the spring. Rolling reviews are underway by the MHRA to assess the Janssen and Novavax vaccines.

The vaccines are available free of charge and are available from thousands of vaccine centres, GP practices and pharmacies, and we want everyone to take up the offer of an appointment when they are invited - all those 50 and over can book a jab now. Around 98% of people live within 10 miles of a vaccination centre in England, which includes mosques, Westminster Abbey and football stadiums.